Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för pemafibrate. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

39 träffar

Bibliografisk träff 2023-01-10

Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration.

Lee D, Nakai A, Miwa Y, Negishi K, Tomita Y, Kurihara T.

PeerJ · research support, non-u.s. gov't; research-article; journal article · DOI 10.7717/peerj.14611

Bibliografisk träff 2022-12-30

Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study.

Morishita A, Oura K, Takuma K, Nakahara M, Tadokoro T, Fujita K, Tani J, Shi T, Himoto T, Tatsuta M, Moriya A, Senoo T, Tsutsui A, Nagano T, Takaguchi K, Ono M, Masaki T.

Hepatol Int · research-article; multicenter study; journal article · DOI 10.1007/s12072-022-10453-1

Bibliografisk träff 2022-12-20

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events.

Izumida T, Imamura T, Narang N, Kinugawa K.

J Clin Med · research-article; journal article · DOI 10.3390/jcm12010021

Bibliografisk träff 2022-11-05

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.

Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM, PROMINENT Investigators.

N Engl J Med · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1056/nejmoa2210645

Bibliografisk träff 2022-04-01

Efficacy and Safety of K-877 (Pemafibrate), a Selective PPARα Modulator, in European Patients on Statin Therapy.

Ginsberg HN, Hounslow NJ, Senko Y, Suganami H, Bogdanski P, Ceska R, Kalina A, Libis RA, Supryadkina TV, Hovingh GK.

Diabetes Care · clinical trial, phase ii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.2337/dc21-1288

Bibliografisk träff 2020-12-14

Correction to: Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet.

Yoshida M, Nakamura K, Miyoshi T, Yoshida M, Kondo M, Akazawa K, Kimura T, Ohtsuka H, Ohno Y, Miura D, Ito H.

Cardiovasc Diabetol · published erratum; correction · DOI 10.1186/s12933-020-01181-7

Bibliografisk träff 2020-09-26

Combination therapy with pemafibrate (K-877) and pitavastatin improves vascular endothelial dysfunction in dahl/salt-sensitive rats fed a high-salt and high-fat diet.

Yoshida M, Nakamura K, Miyoshi T, Yoshida M, Kondo M, Akazawa K, Kimura T, Ohtsuka H, Ohno Y, Miura D, Ito H.

Cardiovasc Diabetol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12933-020-01132-2

Bibliografisk träff 2017-10-01

Pemafibrate: First Global Approval.

Blair HA.

Drugs · review; journal article · DOI 10.1007/s40265-017-0818-x

Bibliografisk träff 2009-02-13

Synthesis of highly deuterium-labeled (R)-K-13675, PPAR alpha agonist, for use as an internal standard for low-level quantification of drugs in plasma.

Yamazaki Y, Ogawa S, Shibuya K.

Bioorg Med Chem · journal article · DOI 10.1016/j.bmc.2009.01.049